Gastroesophageal Reflux Disease (GERD) Clinical Trial
— REMAINOfficial title:
Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient
Verified date | May 2010 |
Source | AstraZeneca |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
The purpose of this study is to describe common treatment pathways, to collect health care utilization data and to assess symptom load as well as impact of symptoms on daily life in GERD patients who are partial-responders to PPI treatment.
Status | Completed |
Enrollment | 552 |
Est. completion date | January 2010 |
Est. primary completion date | January 2010 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - At least 6 month history of GERD symptoms - Treated with unchanged optimized PPI treatment for any GERD indication during a consecutive 4 week period - Remaining GERD symptoms despite optimized PPI treatment - Able to read and write in US English, and able to comply with study requirements Exclusion Criteria: - Patients that have not experienced any GERD symptom improvement at all during PPI treatment - Involvement in the planning or conduct of the study - Involvement in any other observational study or in any clinical study at the time of this study or during the last 6 months |
Observational Model: Cohort
Country | Name | City | State |
---|---|---|---|
United States | Research Site | Aliquippa | Pennsylvania |
United States | Research Site | Altamonte Springs | Florida |
United States | Research Site | Atco | New Jersey |
United States | Research Site | Athens | Tennessee |
United States | Research Site | Austin | Texas |
United States | Research Site | Beachwood | Ohio |
United States | Research Site | Belleville | Illinois |
United States | Research Site | Cary | North Carolina |
United States | Research Site | Charleston | South Carolina |
United States | Research Site | Cocoa | Florida |
United States | Research Site | Columbus | Georgia |
United States | Research Site | Concord | California |
United States | Research Site | Dallas | Texas |
United States | Research Site | Dayton | Ohio |
United States | Research Site | Defuniak Springs | Florida |
United States | Research Site | Elkin | North Carolina |
United States | Research Site | Fair Lawn | New Jersey |
United States | Research Site | Florissant | Missouri |
United States | Research Site | Irving | Texas |
United States | Research Site | Jefferson City | Missouri |
United States | Research Site | Lancaster | California |
United States | Research Site | Largo | Florida |
United States | Research Site | Leeds | Alabama |
United States | Research Site | Los Banos | California |
United States | Research Site | Maitland | Florida |
United States | Research Site | Metaire | Louisiana |
United States | Research Site | Miami | Florida |
United States | Research Site | Mishawaka | Indiana |
United States | Research Site | Naples | Florida |
United States | Research Site | New Bern | North Carolina |
United States | Research Site | Newark | Delaware |
United States | Research Site | Ocala | Florida |
United States | Research Site | Orlando | Florida |
United States | Research Site | Palm Harbor | Florida |
United States | Research Site | Peonia | Florida |
United States | Research Site | Pheonix | Arizona |
United States | Research Site | Philadelphia | Pennsylvania |
United States | Research Site | Prince Frederick | Maryland |
United States | Research Site | Roswell | Georgia |
United States | Research Site | Royston | Georgia |
United States | Research Site | San Antonio | Texas |
United States | Research Site | San Marcos | Texas |
United States | Research Site | Snellville | Georgia |
United States | Research Site | Solana Beach | California |
United States | Research Site | Southlake | Texas |
United States | Research Site | Stanley | North Carolina |
United States | Research Site | Statesville | North Carolina |
United States | Research Site | Tampa | Florida |
United States | Research Site | Towson | Maryland |
United States | Research Site | Tucson | Arizona |
United States | Research Site | Vandalia | Ohio |
United States | Research Site | Warwick | Rhode Island |
United States | Research Site | West Jordan | Utah |
Lead Sponsor | Collaborator |
---|---|
AstraZeneca | i3 Innovus |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Quality of life, productivity loss, frequency and severity of GERD symptoms, health care resource use | Collected at enrollment visit and at 3 and 6 month follow-up. (Health care resource use is at enrollment visit collected retrospectively 6 months) | No | |
Primary | Utility values | Collected at enrollment visit and at 6 month follow-up. | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03561883 -
Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)
|
Phase 3 | |
Completed |
NCT01406210 -
RESULT (REflux Surgery in Lung Transplantation) Preliminary Study Protocol
|
N/A | |
Completed |
NCT02555852 -
Proton Pump Inhibitors and Risk of Community-acquired Pneumonia
|
N/A | |
Terminated |
NCT01327963 -
Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study
|
N/A | |
Completed |
NCT01570842 -
Anthropometry in Gastroesophageal Reflux Disease and Esophageal Injury
|
N/A | |
Completed |
NCT02141711 -
TAK-438 - Safety, Blood Levels & Effects of Repeated Doses
|
Phase 1 | |
Terminated |
NCT00587275 -
Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI
|
Phase 2 | |
Completed |
NCT00228527 -
Esomeprazole for Treatment of GERD in Pediatric Patients
|
Phase 4 | |
Completed |
NCT00261300 -
Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)
|
Phase 3 | |
Recruiting |
NCT04506593 -
Indiana University Gastrointestinal Motility Diagnosis Registry
|
||
Completed |
NCT00394472 -
Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients
|
Phase 2 | |
Completed |
NCT00574925 -
Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients
|
Phase 4 | |
Terminated |
NCT02749071 -
An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Reflux
|
N/A | |
Recruiting |
NCT01129713 -
Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.
|
Phase 1/Phase 2 | |
Completed |
NCT00734747 -
Safety and Efficacy the Medigus SRS Endoscopic Stapling System in Gastroesophageal Reflux Disease (GERD)
|
Phase 3 | |
Completed |
NCT00312806 -
Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)
|
Phase 3 | |
Not yet recruiting |
NCT05579587 -
Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients
|
||
Recruiting |
NCT02366169 -
Medigus Ultrasonic Surgical Endostapler (MUSE) Registry
|
N/A | |
Completed |
NCT01374074 -
Racial Disparity in Barrett's Esophagus
|
N/A | |
Terminated |
NCT00857597 -
Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment
|
Phase 3 |